Prestige Wealth Management Group LLC
Position in STOK — Stoke Therapeutics, Inc.
CIK 1772715
FLEMINGTON, NJ
Position in STOK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,544
+$32 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#171
of 196 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prestige Wealth Management Group LLC holds $465,680 across 25 Biotechnology names. STOK ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
556 | $276,181 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
201 | $60,507 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63 | $39,282 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
7,750 | $16,972 | |
| 5 | INCY |
Incyte Corp
|
132 | $14,963 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
124 | $10,107 | |
| 7 | MRNA |
Moderna, Inc.
|
137 | $9,594 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
This page
|
200 | $6,544 |
All Filings in STOK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,544 | 200 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,512 | 200 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,348 | 200 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||